首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Mechanism of protective immunity by vaccination with recombinant Echinococcus granulosus glutathione S-transferase (Chinese strain) in mice
【2h】

Mechanism of protective immunity by vaccination with recombinant Echinococcus granulosus glutathione S-transferase (Chinese strain) in mice

机译:重组粒棘球chin谷胱甘肽S-转移酶(中国品系)疫苗接种后的保护性免疫机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to investigate the immunoprotective effects of recombinant Echinococcus granulosus glutathione S-transferase (rEgGST) against the development of protoscolices (PSCs), and to determine the mechanisms underlying this protection. ICR mice were subcutaneously immunized three times with rEgGST at weeks 0, 2 and 4, followed by the intraperitoneal administration of E. granulosus PSCs at week 10. Six mice in each group were sacrificed at 0, 2, 4, 6, 10, 18 and 30 weeks following the initial vaccination in order to observe the macroscopic and microscopic effects of parasite development. Various analyses were subsequently conducted, including determination of the levels of immunoglobulins (Igs) and cytokines. Significant differences were observed a number of indices of immune response following immunization with rEgGST. These included reduced cyst formation and elevated levels of IgG1, IgG2a, IgG3, IL-2, IL-4, IL-10 and IFN-γ, which indicated an increased percentage of immune helper cells. The results of the present study suggest that immunization with rEgGST in mice is able to successfully reduce the PSC-induced formation of cysts and to stimulate an immune response, suggesting that rEgGST possesses potential value as a candidate vaccine for PSC infection.
机译:这项研究的目的是调查重组细粒棘球glut谷胱甘肽S-转移酶(rEgGST)对原壳(PSCs)的发展的免疫保护作用,并确定这种保护机制。在第0、2和4周用rEgGST皮下免疫ICR小鼠3次,然后在第10周腹膜内给予颗粒肠埃希氏菌(PSC)。每组分别在0、2、4、6、10、18处死6只小鼠初次接种疫苗后30周,以观察寄生虫发育的宏观和微观影响。随后进行了各种分析,包括确定免疫球蛋白(Igs)和细胞因子的水平。在用rEgGST免疫后,观察到许多免疫反应指标的显着差异。这些包括减少的囊肿形成和升高的IgG1,IgG2a,IgG3,IL-2,IL-4,IL-10和IFN-γ水平,这表明免疫辅助细胞的百分比增加。本研究的结果表明,在小鼠中用rEgGST免疫能够成功减少PSC诱导的囊肿形成并刺激免疫反应,这表明rEgGST具有作为PSC感染候选疫苗的潜在价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号